References

Awasthi S, Spellman DS, Hatcher NG Proteomic discovery and validation of novel fluid biomarkers for improved patient selection and prediction of clinical outcomes in Alzheimer's disease patient cohorts. Proteomes. 2022; 10:(3) https://doi.org/10.3390/proteomes10030026

Bae J, Sung HK, Kwon NY Cognitive behavioral therapy for migraine headache: a systematic review and meta-analysis. Medicina (Kaunas, Lithuania). 2021; 58:(1) https://doi.org/10.3390/medicina58010044

Bavikatte G, Subramanian G, Ashford S, Allison R, Hicklin D Early identification, intervention and management of post-stroke spasticity: expert consensus recommendations. J Cent Nerv Syst Dis. 2021; https://doi.org/10.1177/11795735211036576

Bennett S, Laver K, Voigt-Radloff S Occupational therapy for people with dementia and their family carers provided at home: a systematic review and meta-analysis. BMJ Open. 2019; 9:(11) https://doi.org/10.1136/bmjopen-2018-026308

Bhatti GK, Reddy AP, Reddy PH, Bhatti JS Lifestyle modifications and nutritional interventions in aging-associated cognitive decline and Alzheimer's disease. Front Aging Neurosci. 2020; 11 https://doi.org/10.3389/fnagi.2019.00369

Chen HY, Albertson TE, Olson KR Treatment of drug-induced seizures. Br J Clin Pharmacol. 2016; 81:(3)412-419 https://doi.org/10.1111/bcp.12720

de Oliveira RMW Neuroplasticity. J Chem Neuroanat. 2020; 108:101822-101822 https://doi.org/10.1016/j.jchemneu.2020.101822

DeTure MA, Dickson DW The neuropathological diagnosis of Alzheimer's disease. Mol Neurodegener. 2019; 14:(1) https://doi.org/10.1186/s13024-019-0333-5

Digre KB Headaches and other head pain. Chapter 370, 26th edn. In: Goldman L, Schafer AI (eds). : Elsevier; 2019

Dunn AR, O'Connell KMS, Kaczorowski CC Gene-by-environment interactions in Alzheimer's disease and Parkinson's disease. Neurosci Biobehav Rev. 2019; 103:73-80 https://doi.org/10.1016/j.neubiorev.2019.06.018

Feigin VL, Nichols E, Alam T Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019; 18:(5)459-480 https://doi.org/10.1016/S1474-4422(18)30499-X

The International Classification of Headache Disorders. Cephalalgia. 2018; 38:(1)1-211 https://doi.org/10.1177/0333102417738202

Ingvaldsen SH, Tronvik E, Brenner E A biofeedback app for migraine: development and usability study. JMIR Formative Research. 2021; 5:(7) https://doi.org/10.2196/23229

Indiana University School of Medicine. Human structure virtual histology: nerve tissue. 2016. https//vmicro.iusm.iu.edu/hs_vm/docs/lab5_2.htm (accessed 8 February 2024)

Kang MJ, Kim SM, Han SE Effect of paper-based cognitive training in early stage of Alzheimer's dementia. Dement Neurocogn Disord. 2019; 18:(2)62-68 https://doi.org/10.12779/dnd.2019.18.2.62

Kilinc E, Guerrero-Toro C, Zakharov A Serotonergic mechanisms of trigeminal meningeal nociception: implications for migraine pain. Neuropharmacology. 2017; 116:160-173 https://doi.org/10.1016/j.neuropharm.2016.12.024

Kim YS, Choi J, Yoon BE Neuron-glia interactions in neurodevelopmental disorders. Cells. 2020; 9:(10) https://doi.org/10.3390/cells9102176

Litke R, Garcharna LC, Jiwani S, Neugroschl J Modifiable risk factors in Alzheimer disease and related dementias: a review. Clin Ther. 2021; 43:(6)953-965 https://doi.org/10.1016/j.clinthera.2021.05.006

Liu W, Zhang J, Wang Y, Li J, Chang J, Jia Q Effect of physical exercise on cognitive function of Alzheimer's disease patients: a systematic review and meta-analysis of randomized controlled trial. Front Psychiatry. 2022; 13 https://doi.org/10.3389/fpsyt.2022.927128

Lucas MJ, Brouwer MC, van der Ende A, van de Beek D Outcome in patients with bacterial meningitis presenting with a minimal Glasgow Coma Scale score. Neurol Neuroimmunol Neuroinflamm. 2014; 1:(1) https://doi.org/10.1212/NXI.0000000000000009

Martins-Macedo J, Lepore AC, Domingues HS, Salgado AJ, Gomes ED, Pinto L Glial restricted precursor cells in central nervous system disorders: current applications and future perspectives. Glia. 2021; 69:(3)513-531 https://doi.org/10.1002/glia.23922

Maschio C, Ni R Amyloid and tau positron emission tomography imaging in alzheimer's disease and other tauopathies. Front Aging Neurosci. 2022; 14 https://doi.org/10.3389/fnagi.2022.838034

National Institute for Health and Care Excellence. Meningitis (bacterial) and meningococcal septicaemia in under 16s: recognition, diagnosis and managemen. NICE clinical guideline CG102. 2015. https//www.nice.org.uk/guidance/cg102 (accessed 8 February 2024)

National Institute for Health and Care Excellence. Dementia: assessment, management and support for people living with dementia and their carers. NICE guideline NG97. 2018. https//www.nice.org.uk/guidance/ng97 (accessed 8 February 2024)

National Institute for Health and Care Excellence. Information for the public - treatments for migraine. Based on CG150: Headaches in over 12s: diagnosis and management. 2021. https//www.nice.org.uk/guidance/cg150/ifp/chapter/treatments-for-migraine (accessed 8 February 2024)

National Institute for Health and Care Excellence. Stroke and transient ischaemic attack in over 16s: diagnosis and initial management. NICE guideline NG128. 2022a. https//www.nice.org.uk/guidance/ng128 (accessed 8 February 2024)

National Institute for Health and Care Excellence. Epilepsy in children, young people and adults. NICE guideline NG217. 2022b. https//www.nice.org.uk/guidance/ng217

National Institute for Health and Care Excellence. Suspected neurological conditions: recognition and referral. NG 127. 2023. https//www.nice.org.uk/guidance/ng127 (accessed 9 February 2024)

National Institute of Neurological Disorders and Stroke. Epilepsy and seizures. 2023. https//www.ninds.nih.gov/health-information/disorders/epilepsy-and-seizures (accessed 8 February 2024)

Neurological Alliance. Neuro numbers 2019. 2019. https//www.neural.org.uk/wp-content/uploads/2021/04/neuro-numbers-2019-1.pdf (accessed 8 February 2024)

NHS. Epilepsy: overview. 2020. https//www.nhs.uk/conditions/epilepsy (accessed 8 February 2024)

Office for National Statistics. Death registration summary statistics, England and Wales: 2022. Number of deaths by leading cause of death. 2023. http//tinyurl.com/5bw7c35u (accessed 8 February 2024)

Øie LR, Kurth T, Gulati S, Dodick DW Migraine and risk of stroke. J Neurol Neurosurg Psychiatry. 2020; 91:(6)593-604 https://doi.org/10.1136/jnnp-2018-318254

Parikh SR, Campbell H, Bettinger JA The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. J Infect. 2020; 81:(4)483-498 https://doi.org/10.1016/j.jinf.2020.05.079

Pedroso RV, Corazza DI, Andreatto CAA, Silva TMV, Costa JLR, Santos-Galduróz RF Cognitive, functional and physical activity impairment in elderly with Alzheimer's disease. Dement Neuropsychol. 2018; 12:(1)28-34 https://doi.org/10.1590/1980-57642018dn12-010004

Resuscitation Council UK. The ABCDE approach. 2021. https//www.resus.org.uk/library/abcde-approach (accessed 8 February 2024)

Royal College of Physicians. National Early Warning Score (NEWS) 2: Standardising the assessment of acute-illness severity in the NHS. 2017. https//tinyurl.com/ycodbu85 (accessed 8 February 2024)

Safak B, Altunan B, Topçu B, Eren Topkaya A The gut microbiome in epilepsy. Microb Pathog. 2020; 139 https://doi.org/10.1016/j.micpath.2019.103853

, 2nd edn. In: Saver JL, Hankey GJ (eds). : Cambridge University Press; 2020

Silva-Néto RP, de Almeida Soares A, Augusto Carvalho de Vasconcelos C, da Silva Lopes L Watermelon and others plant foods that trigger headache in migraine patients. Postgrad Med. 2021; 133:(7)760-764 https://doi.org/10.1080/00325481.2021.1922211

Tavakolian S, Goudarzi H, Eslami G, Darazam IA, Dehghan G, Faghihloo E Detection of enterovirus, herpes simplex, varicella zoster, epstein-barr and cytomegalovirus in cerebrospinal fluid in meningitis patients in Iran. J Clin Lab Anal. 2021; 35:(7) https://doi.org/10.1002/jcla.23836

Tsang RSW A narrative review of the molecular epidemiology and laboratory surveillance of vaccine preventable bacterial meningitis agents: streptococcus pneumoniae, neisseria meningitidis, haemophilus influenzae and streptococcus agalactiae. Microorganisms. 2021; 9:(2) https://doi.org/10.3390/microorganisms9020449

UK Health Security Agency. Haemophilus influenzae: guidance, data and analysis. 2022. http//tinyurl.com/2s3dp929 (accessed 9 February 2024)

Urits I, Patel M, Putz ME Acupuncture and its role in the treatment of migraine headaches. Neurol Ther. 2020; 9:(2)375-394 https://doi.org/10.1007/s40120-020-00216-1

Wang G, Estrella A, Hakim O Mini-Mental State Examination and Montreal Cognitive Assessment as tools for following cognitive changes in alzheimer's disease neuroimaging initiative participants. J Alzheimers Dis. 2022; 90:(1)263-270 https://doi.org/10.3233/JAD-220397

Waugh A, Grant A Ross and Wilson anatomy and physiology in health and illness, 14th edn. : Elsevier Health Sciences; 2022

Weatherall MW The diagnosis and treatment of chronic migraine. Ther Adv Chronic Dis. 2015; 6:(3)115-123 https://doi.org/10.1177/2040622315579627

World Health Organization. Improving the lives of people with epilepsy: a technical brief. 2022. https//www.who.int/publications/i/item/9789240064072 (accessed 8 February 2024)

World Health Organization. Noncommunicable diseases. Fact sheet. 2023a. https//www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases (accessed 8 February 2024)

World Health Organization. Meningitis. Key facts. 2023b. https//www.who.int/news-room/fact-sheets/detail/meningitis (accessed 9 February 2024)

The nervous system and associated disorders

22 February 2024
Volume 33 · Issue 4

Abstract

Disorders of the nervous system, encompassing the brain, spinal cord and peripheral nerves, have emerged as a significant public health issue, with profound implications for individuals worldwide. These conditions result in significant morbidity and mortality. Many patients with neurological disorders often have comorbidities, further complicating their clinical presentation. Therefore, nurses must possess a comprehensive understanding of the nervous system and its associated disorders to formulate detailed care plans that address the unique needs of each patient. This article aims to explore the underlying pathophysiology of some of the most prevalent neurological disorders and how this informs effective patient assessment and diagnostic strategies. A further article will build on this to consider patient assessment and formulating a care plan in more detail.

The nervous system is an incredibly complex system of cells, tissues and organs that plays a vital role in the control and regulation of all bodily functions. When the nervous system is disrupted, it can lead to a variety of disorders which can impact on a person's quality of life.

Nervous system disorders, also known as neurological disorders, refer to a broad range of conditions that can affect various parts of the nervous system, including the brain, spinal cord and nerves. The incidence of these disorders can vary greatly depending on the specific condition and geographical location. According to the World Health Organization ((WHO), 2023a), neurological disorders are a major public health problem affecting millions of people worldwide. Moreover, neurological disorders are one of the leading causes of disability worldwide (Feigin et al, 2019). In the UK, neurological disorders are a common and significant health problem. Approximately one in six people living in England have one or more neurological disorders (Neurological Alliance, 2019), and neurological disorders were two of the top five leading causes of death in England and Wales (Office for National Statistics 2023) (Table 1).


Table 1. Leading causes of death in England and Wales, 2022
Causes of death n %
Dementia and Alzheimer's disease 65 967 11.4
Ischaemic heart diseases 59 356 10.3
Chronic lower respiratory diseases 29 815 5.2
Cerebrovascular diseases 29 274 5.1
Malignant neoplasm of trachea, bronchus and lung 28 571 5.0
Source: Office for National Statistics, 2023

The nervous system: an overview

The nervous system is a complex network of specialised cells called neurons, which transmit electrical and chemical signals throughout the body to communicate with and control other cells. It is divided into two main parts: the central nervous system (CNS) and the peripheral nervous system (PNS) (Figure 1).

Figure 1. Organisation of the nervous system

Neurons

Neurons, also known as nerve cells, are the primary functional unit of the nervous system and are responsible for transmitting electrical and chemical signals throughout the body. The structure of a neuron consists of a cell body, dendrites, and an axon (Figure 2). The cell body contains the nucleus and other organelles that are responsible for the cell's metabolism. Dendrites are branched extensions that receive signals from other neurons or sensory cells. Axons are long, slender extensions of the cell body that transmit signals to other neurons or to muscles or glands.

Figure 2. Structure of a neuron

Although the neurons are the cells responsible for transmitting information throughout the nervous system, glial cells play important roles in supporting and protecting neurons, and in maintaining the chemical environment of the nervous system. There are several types of glial cells, each of which has a specific set of functions and characteristics (Table 2). Their dysfunction has been implicated in a variety of neurological and psychiatric disorders (Kim et al, 2020; Martins-Macedo et al, 2021).


Table 2. Types, location, and major functions of glial cells
Glial cell Location Major functions
Astrocytes Central nervous system Provide structural and metabolic support; participate in repair
Ependymal cells Central nervous system, line central canal, and ventricles Assist in the production and movement of cerebrospinal fluid
Microglia Central nervous system Participate in defence and immune responses
Oligodendrocytes Central nervous system Produce myelin and provide electrical insulation
Satellite cells Peripheral nervous system, peripheral ganglia Provide structural and metabolic support for cell bodies of neurons
Schwann cells Peripheral nervous system, peripheral nerves Produce myelin and provide electrical insulation
Source: Adapted from Indiana University School of Medicine, 2016

Central nervous system

The CNS is made up of the brain and spinal cord and is responsible for receiving and interpreting information from the PNS and sending out appropriate signals to control bodily functions. It is protected by three layers of membranes, known as meninges, and is bathed in cerebrospinal fluid (CSF), which provides cushioning and support.

The brain is the control centre of the nervous system and is responsible for receiving, processing and transmitting sensory information from the body. It is protected by the skull and its structure comprises three main parts: the cerebrum, cerebellum, and brainstem. The cerebrum is the largest part of the brain and is responsible for conscious thought, movement, sensation, and perception. The cerebellum is involved in coordination, balance and muscle control, while the brainstem controls basic life functions such as breathing, heart rate and blood pressure (Waugh and Grant, 2022). In addition to its many functions, the brain has also a property called neuroplasticity, meaning it can change and adapt in response to new experiences and learning. Indeed, neuroplasticity is what allows the acquisition of new skills, recovery from injuries, and adaptation to changing environments throughout the lifespan (de Oliveira, 2020).

The spinal cord is a long, cylindrical bundle of nerve fibres that extends from the brainstem to the lower back. It acts as a pathway for signals travelling between the brain and the rest of the body and it is protected by the vertebrae of the spine. Different regions of the spinal cord correspond to specific zones of the body, allowing for precise control and coordination of movement and sensation. If a specific segment of the spinal cord is injured, it results in a corresponding loss of function or sensation in the specific area of the body that is served by that particular region of the spinal cord (Figure 3).

Figure 3. Spinal cord regions and corresponding dermatomes (areas of the skin with sensory connections to particular spinal nerves)

Peripheral nervous system

The PNS consists of all the nerves outside the CNS. These nerves are divided into two types: sensory nerves, which carry information from the sensory organs (such as the eyes and ears) to the CNS, and motor nerves, which carry signals from the CNS to the muscles and organs, causing them to move or perform their functions. Furthermore, the PNS is divided into two parts: the somatic nervous system and the autonomic nervous system. The somatic nervous system controls voluntary movements and sensory perception, while the autonomic nervous system controls many of the body's automatic functions, such as heart rate, digestion and respiration. The autonomic nervous system is further divided into the sympathetic and parasympathetic systems, which work together to maintain balance and regulate the body's response to different stimuli (Figure 1).

Assessment of the nervous system

Assessing the nervous system can be a complex process and can involve a range of tests and evaluations, depending on the specific concerns or symptoms that are present. For a comprehensive assessment of the structure, function, and ability of the nervous system to respond to stimuli, a multitude of methods is considered; the most common are as follows:

  • Medical history: collecting data about previous medical conditions or injuries, any relevant family history, and current symptoms can help identify potential and/or active nervous system issues
  • Physical examination: at a physical level, this should comprise an ABCDE assessment (Resuscitation Council UK, 2021), with a focus on cranial nerve examination, motor examination, sensory examination, and reflex examination (National Institute for Health and Care Excellence (NICE), 2023). An understanding of the sensory nerve connections from different areas of the skin through the spinal cord (Figure 3) can help identify a spinal cord injury
  • Mental status examination: this involves evaluating a person's cognitive abilities, including memory, orientation, attention, language, and executive function. When assessing the patient's consciousness level, tools such as ACVPU (Table 3) and the Glasgow Coma Scale (https://www.glasgowcomascale.org/) should be considered
  • Imaging tests: tests such as magnetic resonance imaging (MRI) or computed tomography (CT) scans can provide images of the brain, spinal cord and nerves. These tests can help detect abnormalities, such as tumours, lesions or inflammation
  • Electrophysiological tests: electroencephalogram (EEG) and electromyogram (EMG) are examples of tests that can measure the electrical activity of the nervous system. These tests are used to diagnose a variety of neuromuscular diseases, nerve injuries and nervous degenerative conditions
  • Nerve conduction studies: these tests measure the speed and strength of nerve impulses. They can help diagnose conditions such as carpal tunnel syndrome, peripheral neuropathy, or nerve injuries
  • Laboratory tests: blood and CSF tests can be used to detect certain neurological conditions, such as infections, autoimmune diseases or vitamin deficiencies.

Table 3. ACVPU assessment of level of consciousness, used in the National Early Warning Score 2
A Alert The patient is awake
C Acute Confusion New onset of confusion, disorientation, delirium, or any new alteration to mentation
V Voice The patient requires a verbal stimulus to initiate a response
P Pain The patient requires a pain stimulus to initiate a response
U Unresponsive Unresponsive to all stimuli
Royal College of Physicians, 2017

Disorders of the nervous system

Neurological disorders can be broadly classified into several categories based on their underlying causes, symptoms, and affected areas of the nervous system. The major categories of neurological disorder are listed and briefly described in Table 4; some examples of neurological disorder are also included for each category. The list demonstrates the range of possible disorders that can affect the nervous system is, all of them with great potential to affect a person's quality of life.


Table 4. Main categories of neurological disorders
Category Description Examples
Structural Affecting the structure of the brain or other parts of the nervous system Tumours, aneurysms, malformations
Degenerative Involving the progressive loss of nerve cells or other components of the nervous system Alzheimer's disease, Parkinson's disease, Huntington's disease
Vascular Affecting the blood vessels in the brain or other parts of the nervous system Stroke, cerebral haemorrhage
Infectious Caused by infections in the nervous system Meningitis, encephalitis
Traumatic Resulting from physical injuries to the brain or other parts of the nervous system Concussion, spinal cord injury
Functional Involving changes in the way the nervous system functions, without any apparent structural or biochemical abnormalities Epilepsy, migraine, multiple sclerosis
Developmental Arising during the development of the nervous system Cerebral palsy, autism spectrum disorders, intellectual disability
Autoimmune Resulting from an abnormal immune response that attacks the nervous system Multiple sclerosis, myasthenia gravis
Metabolic Affecting the metabolism of the nervous system Tay-Sachs disease, phenylketonuria

The five largest contributors to global neurological disability-adjusted life-years (DALYs: a measure of overall disease burden, expressed as the number of years lost as a result of ill-health, disability, or premature death) are stroke, migraine, Alzheimer's disease, meningitis and epilepsy (Feigin et al, 2019).

Stroke

A stroke is caused by interrupted blood supply to the brain – a blockage in a blood vessel (ischaemic stroke) or a ruptured vessel (haemorrhagic stroke). Risk factors for stroke include hypertension, smoking, diabetes, hypercholesterolaemia, atrial fibrillation, obesity, sedentariness, family history of stroke, age, sex and race (Saver and Hankey, 2020).

Signs and symptoms are sudden paraesthesia and/or paresis on one side of the body, dysarthria or aphasia, vision impairment in one or both eyes, confusion, dizziness, vertigo and severe headache. Diagnostic tests and investigations include brain imaging tests (CT or MRI scan), carotid ultrasound and angiogram.

Treatment for stroke involves (NICE, 2022a):

  • Intravenous thrombolysis with alteplase within the first 4.5 hours of stroke symptoms for confirmed ischaemic stroke
  • Thrombectomy if the patient meets the required criteria
  • Anticoagulation with aspirin
  • Statins (only if already receiving such treatment for other comorbidities) for ischaemic strokes
  • Focus on haemostasis and reducing blood and intracranial pressures for haemorrhagic strokes.

Preventive measures involve managing underlying health conditions (eg, hypertension, diabetes), smoking cessation, regular physical exercise, maintaining a healthy weight, limiting alcohol consumption, and early detection and treatment of stroke symptoms (Bavikatte et al, 2021).

Migraine

The exact cause of migraine is not fully understood but might be related to changes in the levels of certain chemicals in the brain, including serotonin (Kilinc et al, 2017).

Triggers include hormonal changes (eg, oestrogen, progesterone), stress, changes in sleep patterns, and certain foods such as alcohol, aspartame sweetener, beans and other tyramine-containing foods, caffeine, cheeses and yoghurt, soups and foods containing monosodium glutamate, or processed meats containing sulphites (Silva-Néto et al, 2021).

Signs and symptoms vary from person to person but typically include a throbbing or pulsating headache, sensitivity to light and sound, nausea and vomiting, and auras (Weatherall, 2015; Digre, 2019).

Diagnosis comprises a thorough medical history and physical examination to rule out other possible causes of headaches. Brain imaging tests (MRI or CT scans) may be used for differential diagnosis, and the International Classification of Headache Disorders (ICHD) criteria (Headache Classification Committee of the International Headache Society, 2018).

Treatments for migraine include analgesics (eg, paracetamol and non-steroidal anti-inflammatory drugs), triptans and anti-emetics to manage the symptoms. Prophylactic medication (beta blockers or antidepressants) may also be prescribed (NICE, 2021). Patients will be advised on lifestyle changes (adequate sleep, stress reduction, healthy diet, trigger identification/avoidance, relaxation techniques) and other potential preventive measures include cognitive behavioural therapy and biofeedback, acupuncture (Urits et al, 2020; Bae et al, 2021; Ingvalsden et al, 2021).

Early diagnosis and prompt management of migraine is essential to avoid complications, such as status migrainosus or even stroke (Øie et al, 2020).

Alzheimer's disease

The most common type of dementia, Alzheimer's disease, involves a build-up of amyloid plaques and tau tangles in the brain (DeTure and Dickson, 2019). The exact causes are not fully understood but genetic, environmental and lifestyle factors may be involved (Dunn et al, 2019). Risk factors include age, family history, head injuries, hypertension, hypercholesterolaemia and diabetes (Litke et al, 2021).

Signs and symptoms are memory loss and confusion (this may be mild in the early stages), cognitive impairment (language difficulties, disorientation) and mood and behaviour changes. As the disease progresses, people with Alzheimer's disease will have difficulty with basic activities of daily living (eg, eating, bathing, dressing) (Pedroso et al, 2018).

Diagnosis involves a thorough medical history and cognitive function tests (Mini-Mental State Examination, Montreal Cognitive Assessment) (Wang et al, 2022), brain imaging tests (MRI or CT scans) and potentially positron emission tomography scans to detect abnormal protein deposits in the brain (Maschio and Ni, 2022) Treatment for Alzheimer's disease involves medications to manage memory loss and cognitive symptoms (eg, cholinesterase inhibitors), non-pharmacological interventions such as occupational therapy and speech therapy, and lifestyle modifications promoting physical exercise, healthy eating and social engagement (NICE, 2018; Bennett et al, 2019; Bhatti et al, 2020).

There is no cure yet available but clinical trials of drugs targeting amyloid plaques and tau tangles (Awasthi et al, 2022) and lifestyle interventions such as cognitive training and physical exercise (Kang et al, 2019; Liu et al, 2022) have shown promising early results to slow or stop the progression of the disease.

Meningitis

Bacterial meningitis (the most common form) is caused by bacteria such as Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae (in particular, type b or Hib) (Tsang, 2021; UK Health Security Agency, 2022); they can be spread through respiratory secretions, such as coughing and sneezing, or through direct contact with an infected person (WHO, 2023b).

Viral meningitis is caused by viruses including enteroviruses, herpes simplex virus and varicella zoster virus (Tavakolian et al, 2021); the responsible virus is usually spread through contact with contaminated faecal matter or respiratory secretions, or can be transmitted through insect bites (WHO, 2023b).

Symptoms of meningitis are fever, headache, stiff neck, nausea, vomiting, photophobia, confusion and seizures. Signs in infants and young children also include lethargy, poor feeding and irritability. In severe cases there may be seizures, loss of consciousness or coma (Lucas et al, 2014).

Investigations include a physical examination, blood tests (full blood count, C-reactive protein, procalcitonin, blood cultures), and a lumbar puncture for CSF analysis. Imaging studies may also be used.

Management of bacterial meningitis is immediate hospitalisation and treatment with intravenous antibiotics. Viral meningitis usually resolves on its own with supportive care. Supportive care for both types may include intravenous fluids, oxygen therapy, and medication for fever, seizures and pain (NICE, 2015). Prevention is through vaccination and good hygiene practices (Parikh et al, 2020; WHO, 2023b).

Epilepsy

Although epilepsy can affect people of all ages, races, and backgrounds, it is most commonly diagnosed in childhood or in people over the age of 65 years. Some people may only have one seizure in their lifetime, while others may experience multiple seizures a day (NHS, 2020).

Causes are not always clear, but can include brain injury, genetic factors, infections, tumours and other medical conditions. In some cases, it may be idiopathic (Şafak et al, 2020)

Seizures can be triggered by a variety of factors, including stress, lack of sleep, flashing lights (National Institute of Neurological Disorders and Stroke, 2023), and certain medications, such as antidepressants, diphenhydramine, tramadol and isoniazid (Chen et al, 2016). There may be sudden and temporary changes in behaviour, movement, sensation or emotion. A person with epilepsy may have convulsions and loss of consciousness, or there may be brief periods of staring, confusion or muscle jerking.

Investigations include an EEG, MRI and blood tests such as full blood count, urea and electrolytes, liver function tests, glucose and calcium (NICE, 2022b) to identify conditions that may be triggering the seizures (such as infections, iron deficiency, anaemia or diabetes).

One form of treatment is anti-seizure medications (eg, levetiracetam), which can help control the frequency and severity of seizures (NICE, 2022b). In some cases, surgery may be recommended to remove part of the brain responsible for the seizures. Other interventions include dietary changes such as a ketogenic diet, and lifestyle modifications to reduce seizure triggers (NICE, 2022b). Close collaboration between the patient and healthcare providers is key, to develop a personalised treatment plan (WHO, 2022).

Conclusion

Understanding the nervous system enables nurses to perform accurate assessments, identify early signs of neurological dysfunction, and intervene promptly. It empowers them to recognise potential complications, manage symptoms effectively, and provide appropriate support to patients and their families. Neurological conditions, such as stroke, can have profound effects on individuals' physical, cognitive and emotional wellbeing. By developing a comprehensive understanding of the nervous system and associated disorders, nurses can provide competent and compassionate care, tailored to each patient's unique needs. The second part of this discussion will build on this to consider patient assessment in more detail and emphasise the importance of facilitating patient self-management for improved outcomes.

KEY POINTS

  • The nervous system plays an important role in coordinating bodily functions and responses, maintaining homeostasis and transmitting signals throughout the body
  • Disorders of the nervous system, such as stroke, migraine, Alzheimer's disease, meningitis and epilepsy, can significantly impact on a person's quality of life and functionality
  • Timely and comprehensive assessment of individuals with neurological disorders is essential to detect changes in symptoms, functional abilities and cognitive status, allowing for early intervention and improved outcomes
  • Without prompt and accurate assessment, individuals with neurological disorder may experience delays in receiving appropriate care, leading to increased risk of complications and diminished quality of life
  • Nurses must possess a comprehensive understanding of neurological disorders, their classifications, symptoms, treatment options and interventions to deliver effective, patient-centred care and support to individuals and their families

CPD reflective questions

  • How is the nervous system and associated disorders assessed in your clinical area?
  • How can you collaborate with other health professionals to ensure a comprehensive assessment of individuals with neurological disorders, considering the diverse range of symptoms and presentations associated with these conditions?
  • How can you advocate for the integration of nursing assessment as a cornerstone in your clinical team's approach to managing individuals with neurological disorders, recognising its pivotal role in providing comprehensive and patient-centred care?